Magnesium Sulfate Heptahydrate Kalceks (Magnesium Sulfate Heptahydrate)

Magnesium sulfate provides magnesium ions that act as cofactors for many enzymes, block calcium channels, cause vasodilation, reduce neuronal excitability, and stabilise cardiac membranes, thereby preventing seizures, correcting electrolyte deficits, and terminating certain arrhythmias.

The specific dose and infusion rate are determined by the prescribing clinician based on the indication, patient weight, renal function, and serum magnesium levels. Healthcare professionals should follow local guidelines and monitor the patient closely.

Magnesium sulfate is commonly used in obstetric care for eclampsia and preeclampsia, but its safety profile depends on appropriate dosing and monitoring. Pregnant or breastfeeding patients should receive the drug only under direct medical supervision.

Submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain needs) and required import documentation.

Magnesium sulfate heptahydrate is a highly soluble form that can be administered intravenously or intramuscularly, offering rapid bioavailability. Compared with oral magnesium salts, it provides faster correction of severe deficiency and is the preferred choice for obstetric seizure prophylaxis and acute arrhythmia management.

Store the injectable solution at ambient temperature, ideally below 25 °C, in its original sealed container. Protect it from moisture, direct sunlight and extreme temperature fluctuations to maintain potency and sterility.

The drug is supplied as a sterile injectable solution for intramuscular or intravenous administration. Intravenous infusion should be performed slowly, usually over 15–30 minutes, while intramuscular injection is given into a large muscle group according to clinical protocol.

Serious risks include respiratory depression, severe hypotension, cardiac arrest, hypermagnesemia leading to arrhythmias, and rare anaphylactic reactions. Continuous monitoring of vital signs and serum magnesium levels is essential during therapy.

Patients with known hypersensitivity to magnesium sulfate, severe renal impairment, existing heart block or severe cardiac conduction disorders, and those receiving other high‑dose magnesium products should avoid this medication unless closely supervised by a physician.